GCG and anxiety disorder: This is also consistent with a review investigating the efficacy of GLP-1 agonists on cognitive, psychotic, and anxiety disorders in different patient populations; no effect was found for almost all the identified clinical trials for these outcomes (Giorgi et al. 2025).